(Q39496137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Urodynamic Effects of Finasteride in the Treatment of Bladder Outlet Obstruction due to Benign Prostatic Hyperplasia (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

11 August 2024

author name string

T. L. Tammela

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7678871

11 August 2024

M. J. Kontturi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7678871

11 August 2024

language of work or name

English

0 references

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 October 2019

https://api.elsevier.com/content/article/PII:S0022534717360779?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

https://api.elsevier.com/content/article/PII:S0022534717360779?httpAccept=text/plain

11 August 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2936077-9

11 August 2024

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

11 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

342-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

The development of human benign prostatic hyperplasia with age

23 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Origin and evolution of benign prostatic enlargement

11 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

I. The Results of Double Castration in Hypertrophy of the Prostate

11 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled Study

11 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters

11 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases

11 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

11 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Response of the benign hypertrophied prostate to treatment with an LHRH analogue

11 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Treatment of Benign Prostatic Hypertrophy by a Long-Acting Gonadotropin-Releasing Hormone Analogue: 1-Year Experience

11 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group

11 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology

11 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Determination of prostate volume by transrectal ultrasound

11 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy

11 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The incidence of benign prostatic obstruction

11 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

The Assessment of Prostatic Obstruction from Urodynamic Measurements and from Residual Urine

11 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Electron Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia

11 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolide

11 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)36077-9

11 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678871%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference